Angela Macfarlane
Director
Ms. Macfarlane currently serves as CEO of Voyant Biotherapeutics, LLC, an early stage biotech company dedicated to solving age-related macular degeneration. She founded and also serves as a Managing Partner of ForSight Labs, LLC an ophthalmic incubator formed in 2005 in partnership with Dr. Eugene de Juan, Jr. MD, and The Foundry. ForSight has started seven VISION companies in both therapeutics and medical devices — including Transcend Medical, Inc. (acquired by ALCON), ForSight Newco II, Inc. (acquired by QLT), NexisVision, Inc. (licensed), Forsight VISION4, Inc. (acquired by Roche), ForSight VISION5, Inc. (acquired by ALLERGAN), ForSight VISION6, Inc. (private/strategic partnership), and FSV7, LLC (private), focused on developing therapeutics for CNS disorders. Ms. Macfarlane served as the operating CEO of 3 ForSight companies, including as founding CEO through acquisition for ForSight VISION4, Inc. (Acquired by ROCHE), and ForSight VISION5, Inc., (Acquired by Allergan).
Previously, Ms. Macfarlane served as Chief Technology Counsel to The Foundry, a medical technology incubator, and Technology Counsel for Thomas J. Fogarty, M.D., a renowned physician/entrepreneur where she participated in formation and/or development of 9 companies. She previously served on the senior management teams and counsel at TransVascular, Inc. (acquired by Medtronic), AneuRx, Inc. (acquired by Medtronic), and VidaMed Inc. (through IPO).
Ms. Macfarlane is an inventor on 25 U.S. issued patents and received her BA in Business Administration from San Francisco State University, and her J.D. from Golden Gate University School of Law. She currently serves on the board of the Fogarty Institute for Innovation and is a mentor in the Ferolyn Powell Leadership Program.
Management Team
Shaun R. Bagai
Chief Executive Officer
Ramtin Agah, MD
Chief Medical Officer, Founder
Kamran Najmabadi
Chief Technology Officer, Founder
Carole Ann McEvoy
Director of Clinical Operations
Imtiaz Qureshi, MD
Director of Imaging
Richard Taylor
Chief Financial Officer
Mary Hoxworth
Director of Marketing
Board of Directors
Shaun R. Bagai
Chief Executive Officer
Ramtin Agah, MD
Chief Medical Officer, Founder
Laurence J. Marton, MD
Director
Una S. Ryan, PhD, OBE
Director
Advisory Board
Jacob Cynamon, MD
Professor of Clinical Radiology, Albert Einstein College of Medicine Chief, Division of Vascular and Interventional Radiology
Program Director, Vascular and Interventional Radiology Fellowship Program Montefiore Medical Center, Bronx, NY
Mike Pishvaian, MD, PhD
Gastrointestinal Oncologist, Co-Director, Pancreatic Cancer Program at the Reusch Center, Phase
Program Director and Assistant Professor, Lombardi Comprehensive Cancer Center Georgetown University, Washington, D.C.
Peter Muscarella, MD
Director, Pancreatic Surgery General Surgery Site Director, Weiler Hospital
Associate Program Director, General Surgery Residency Training Program Montefiore Medical Center, Bronx, NY
Karyn A. Goodman, MD, MS
Professor of Radiation Oncology
Grohne Chair of Clinical Oncology
University of Colorado, Aurora, CO
Grohne Chair of Clinical Oncology
University of Colorado, Aurora, CO
Daniel D. Von Hoff, MD, FACP
Physician in Chief and Director of Translational Research at TGen (Translational Genomics Research Institute)
Chief Scientific Officer for US Oncology and for HonorHealth’s Clinical Research Institute
Clinical Professor of Medicine, University of Arizona, Tucson, AZ
Emmanuel Zervos, MD
Executive Director of Vidant Cancer Care Chief, Division of Surgical Oncology, East Carolina University Greenville, NC
Reza Malek, MD, MSc
Neurointerventional Radiologist, Minimally Invasive Surgical Solutions San Jose, CA
David C. Madoff, MD, FSIR, FACR
Professor of Radiology Vice Chairman of Academic Affairs Weill Cornell Medical College New York, NY